Concurrent Investment Advisors’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.04M Sell
15,590
-481
-3% -$35.2K 0.01% 984
2026
Q1
$1.23M Buy
16,071
+1,282
+9% +$92.4K 0.01% 805
2025
Q4
$944K Buy
14,789
+465
+3% +$28.7K 0.01% 864
2025
Q3
$903K Buy
14,324
+1,214
+9% +$84.7K 0.02% 685
2025
Q2
$979K Buy
13,110
+2,171
+20% +$171K 0.02% 603
2025
Q1
$964K Buy
10,939
+8,377
+327% +$791K 0.02% 557
2024
Q4
$234K Buy
+2,562
New +$263K 0.01% 929

Other funds holding EMN

Concurrent Investment Advisors's EMN Position: Q2 2026 in Review

Concurrent Investment Advisors reduced its Eastman Chemical (EMN) stake by 3% in Q2 2026, selling an estimated $35.2K and leaving 15,590 shares worth $1.04M. The position accounts for 0.01% of the portfolio, ranked #984.

Concurrent Investment Advisors first reported a position in EMN in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.23M in Q1 2026. 642 funds tracked by Wall St. Rank hold EMN as of Q2 2026.

  • Concurrent Investment Advisors held 15,590 shares of Eastman Chemical worth $1.04M as of Q2 2026.
  • Concurrent Investment Advisors sold 481 Eastman Chemical shares in Q2 2026, an estimated $35.2K.
  • Eastman Chemical made up 0.01% of Concurrent Investment Advisors's portfolio in Q2 2026, its #984 holding.
  • Concurrent Investment Advisors first reported a position in Eastman Chemical in Q4 2024 and has held it in 7 quarters since.
  • Concurrent Investment Advisors's Eastman Chemical position peaked at $1.23M in Q1 2026.
  • 642 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.